We are international
Donate
• about myeloma TEXT SIZE   



Order your free publications online
or download the publications order form to fax to the IMF

IMF PATIENT PUBLICATIONS
THE IMF UNDERSTANDING SERIES
IMF PERIODICALS
The IMF is committed to making information on myeloma treatments available in a format that is easy to read and understand.
Understanding Fatigue

Myeloma patients experience fatigue for a variety of reasons. It can be caused by the disease, by treatment, and by the understandable anxiety and/or depression that affects many. The IMF's new booklet "Understanding Fatigue" contains a thorough examination of the causes of myeloma fatigue, strategies to help cope with it, and suggestions for discussing fatigue with your doctor. Part of the IMF's "Understanding" series, this booklet is an online-only publication.

Understanding Adherence to Oral Cancer Therapy

Understanding Adherence to Oral Cancer Therapy is intended to help myeloma patients and their healthcare providers work together to overcome any and all obstacles to adherence to safe and effective oral cancer therapy.


Understanding Clinical Trials
Clinical trials are used to further test new medications and therapies on human subjects. Whether or not to participate in a clinical trial is one of the critical decisions you and your oncologist may have to make in the course of your cancer treatment.
Understanding High-Dose Therapy with Stem Cell Rescue
High-dose therapy with stem cell rescue, or "stem cell transplant," is an important treatment option for eligible patients with multiple myeloma. Whether part of a first treatment regimen or relapse, it can provide significant remission and survival benefits.

Understanding Pomalyst®
(pomalidomide) capsules

The U.S. Food and Drug Administration (FDA) approved Pomalyst® (pomalidomide) on February 8, 2013, to treat patients with multiple myeloma whose disease progressed after being treated with other cancer drugs.

The National Comprehensive Cancer Network (NCNN) has included pomalidomide plus dexamethasone as a salvage therapy option in patients who have received at least two prior therapies, including lenalidomide and bortezomib, and have demonstrated disease progression on or within 60 days of completion of the last therapy. For steroid-intolerant individuals, the NCNN Multiple Myeloma Panel suggests considering pomalidomide monotherapy.

Understanding Protein Electrophoresis
Production of a single, monoclonal protein (M-protein) is a characteristic feature of multiple myeloma. The test used to measure the amount of monoclonal protein in the blood or urine is protein electrophoresis.

The Myeloma Patient's Guide to Understanding Your Test Results
Myeloma is a complex disease that can have different features in each patient. No single test or study is adequate to tell the whole story about a patient’s status, but used together, test results give a more complete picture than any single test does. It is important for you and your doctor to understand your disease and to know which tests are best for monitoring your myeloma.
Understanding Revlimid®
Learn more about Revlimid® (lenalidomide), approved by the FDA for use in myeloma.

Understanding VELCADE® (bortezomib) for Injection
Part of the IMF's Understanding series, this booklet covers the basics, including: What is VELCADE? How does it work? How is VELCADE given? How is it used in clinical practice today? What are the side effects?
Understanding Kyprolis™ (carfilzomib) for Injection
This booklet discusses Kyprolis, the results of clinical trials with Kyprolis, how and when it is administered, its possible side effects, and how to manage them.

Understanding Thalidomide Therapy
Using thalidomide to treat myeloma is a new idea, but thalidomide itself has been studied for many decades. Much has been learned about how thalidomide works in the treatment of different diseases, and how its side effects can be treated.
Understanding Dexamethasone and Other Steroids
After reading this booklet, you should know what dexamethasone is, how it works, possible side effects, and more.

Understanding Serum Free Light Chain Assays
Learn more about a new type of laboratory test called the serum Free Light Chain assay. This test is also known as the Freelite™ test.
Understanding Bisphosphonate Therapy
What you need to know about bone disease and bisphosphonate therapy. What are bisphosphonates? How do they work? Who should take them and who shouldn't? Side effects.

Understanding Balloon Kyphoplasty
and Myeloma-Induced Vertebral Compression Fractures
This booklet covers everything you need to know about vertebral compression fractures and kyphoplasty. In PDF form for viewing and downloading.